So far, it has not been possible to explain the causes of around half of all rare hereditary diseases. A Munich research team has developed an algorithm that predicts the effects of genetic mutations ...
In a recent study published in Scientific Reports, researchers developed a novel algorithm to analyze large genomic datasets of ribonucleic acid (RNA) viruses, applying it to severe acute respiratory ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of its new HRD-RNA algorithm. This ...
Tempus AI (TEM), announced a collaboration with Genialis, the RNA-biomarker company. The multi-year agreement allows Genialis to leverage Tempus’ multimodal dataset to develop new RNA-based algorithms ...
CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with Genialis, ...
Hosted on MSN
What's going on with Tempus AI stock today?
Tempus AI TEM rose on Wednesday after the company unveiled its new HRD-RNA algorithm, an AI-driven tool designed to improve detection of homologous recombination deficiency (HRD) in tumors. The ...
Efficacy of multimodal thermal therapy combined with immune checkpoint inhibitors and chemotherapy in unresectable pancreatic cancer with liver metastases. This is an ASCO Meeting Abstract from the ...
A machine learning algorithm used gene expression profiles of patients with gout to predict flares. The PyTorch neural network performed best, with an area under the curve of 65%. The PyTorch model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results